These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 4106805
1. An eosinophil leukocyte chemotactic factor of anaphylaxis. Kay AB, Stechschulte DJ, Austen KF. J Exp Med; 1971 Mar 01; 133(3):602-19. PubMed ID: 4106805 [Abstract] [Full Text] [Related]
2. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Kay AB, Shin HS, Austen KF. Immunology; 1973 Jun 01; 24(6):969-76. PubMed ID: 4123965 [Abstract] [Full Text] [Related]
4. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system. Kay AB. Antibiot Chemother (1971); 1974 Jun 01; 19():271-83. PubMed ID: 4142850 [No Abstract] [Full Text] [Related]
5. Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgG1 or IgE antibodies. Undem BJ, Buckner CK, Harley P, Graziano FM. Am Rev Respir Dis; 1985 Feb 01; 131(2):260-6. PubMed ID: 2578761 [Abstract] [Full Text] [Related]
6. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Goetzl EJ, Austen KF. Proc Natl Acad Sci U S A; 1975 Oct 01; 72(10):4123-7. PubMed ID: 1060093 [Abstract] [Full Text] [Related]
7. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527). Wasserman SI, Whitmer D, Geotzl EJ, Austen KF. Proc Soc Exp Biol Med; 1975 Jan 01; 148(1):301-6. PubMed ID: 1129271 [Abstract] [Full Text] [Related]
13. Passive sensitization of guinea-pig skin in vitro for the antigen-induced release of anaphylactic mediators. Jones DG, Kay AB. Clin Exp Immunol; 1974 Feb 01; 16(2):213-22. PubMed ID: 4143274 [Abstract] [Full Text] [Related]
14. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat. Stechschulte DJ, Austen KF, Bloch KJ. J Exp Med; 1967 Jan 01; 125(1):127-47. PubMed ID: 4163357 [Abstract] [Full Text] [Related]
15. The release of four mediators of immediate hypersensitivity from human leukemic basophils. Lewis RA, Goetzl EJ, Wasserman SI, Valone FH, Rubin RH, Austen KF. J Immunol; 1975 Jan 01; 114(1 Pt 1):87-92. PubMed ID: 46247 [Abstract] [Full Text] [Related]
17. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. Kay AB, Austen KF. J Immunol; 1971 Sep 01; 107(3):899-902. PubMed ID: 4105937 [No Abstract] [Full Text] [Related]
18. Differences in responses of rat- and guinea-pig-eosinophils to eosinophil chemotactic factors derived from Angiostrongylus cantonensis. Ishida K, Yoshimura K. Parasite Immunol; 1990 May 01; 12(3):269-83. PubMed ID: 2385443 [Abstract] [Full Text] [Related]
19. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue. Austen KF. Fed Proc; 1974 Nov 01; 33(11):2256-62. PubMed ID: 4139041 [No Abstract] [Full Text] [Related]
20. Modulation of human eosinophil polymorphonuclear leukocyte migration and function. Goetzl EJ. Am J Pathol; 1976 Nov 01; 85(2):419-36. PubMed ID: 793410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]